Nuclear expression of phosphorylated focal adhesion kinase is associated with poor prognosis in human colorectal cancer

Anticancer Research

Volumn 34, Issue 8, 2014, Pages 3969-3974

  Albasri, Abdulkader ^a,b   Fadhil, Wakkas ^a   Scholefield, John H ^c   Durrant, Lindy G ^a   Ilyas, Mohammad ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Tibah University   (Saudi Arabia)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Colorectal cancer; Focal adhesion kinase; Prognosis; TNS4 (CTEN)

Indexed keywords

FOCAL ADHESION KINASE; TENSIN; TENSIN 4; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; TENSINS;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; DISEASE SPECIFIC SURVIVAL; ENZYME PHOSPHORYLATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY TUMOR; PROTEIN EXPRESSION; TUMOR INVASION; CELL NUCLEUS; COLORECTAL TUMOR; METABOLISM; METASTASIS; MORTALITY; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; TISSUE MICROARRAY; TNS4 (CTEN); VERY ELDERLY;

COLORECTAL CANCER; FOCAL ADHESION KINASE; PROGNOSIS; TNS4 (CTEN);

AGED; AGED, 80 AND OVER; CELL NUCLEUS; COLORECTAL NEOPLASMS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; PHOSPHORYLATION; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 84908672375     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Albasri A, Al-Ghamdi S, Fadhil W, Aleskandarany M, Liao YC, Jackson D, Lobo DN, Lo SH, Kumari R, Durrant L, Watson S, Kindle KB and Ilyas M: Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer. Oncogene 30: 2997-3002, 2011.
2. Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, Chapman R and Ilyas M: C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. Journal of Pathology 218: 57-65, 2009.
3. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG and Frame MC: Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nature Cell Biology 4: 632-638, 2002.
4. Basson MD, Sanders MA, Gomez R, Hatfield J, VanderHeide R, Thamilselvan V, Zhang JH and Walsh MF: Focal adhesion kinase protein levels in gut epithelial motility. American Journal of Physiology-Gastrointestinal and Liver Physiology 291: G491-G499, 2006.
5. Brunton VG, Avizienyte E, Fincham VJ, Serrels B, Metcalf CA, 3rd, Sawyer TK and Frame MC: Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res 65: 1335-1342, 2005.
6. Calderwood DA, Fujioka Y, de Pereda JM, Garcia-Alvarez B, Nakamoto T, Margolis B, McGlade CJ, Liddington RC and Ginsberg MH: Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: A structural prototype for diversity in integrin signaling. Proceedings of the National Academy of Sciences of the United States of America 100: 2272-2277, 2003.
7. Camp RL, Dolled-Filhart M and Rimm DL: X-tile: A new bioinformatics tool for biomarker assessment and outcome-based cut-point optimization. Clinical Cancer Research 10: 7252-7259, 2004.
8. Cance WG, Harris JE, Iacocca MV, Roche E, Yang XH, Chang JL, Simkins S and Xu LH: Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clinical Cancer Research 6: 2417-2423, 2000.
9. Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 314: 143-152, 2008.
10. Cui YM, Liao YC and Lo SH: Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. Molecular Cancer Research 2: 225-232, 2004.
11. Davis S, Lu ML, Lo SH, Lin S, Butler JA, Druker BJ, Roberts TM, An Q, and Chen LB: Presence of an SH2 domain in the actin-binding protein tensin. Science 252: 712-715, 1991.
12. Han NM, Fleming RYD, Curley SA and Gallick GE: Overexpression of focal adhesion kinase (p125(FAK)) in human colorectal carcinoma liver metastases: Independence from c-src or c-yes activation. Annals of Surgical Oncology 4: 264-268, 1997.
13. Judson PL, He XP, Cance WG, and Van Le L: Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86: 1551-1556, 1999.
14. Kornberg LJ: Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck 20: 745-752, 1998.
15. Lark AL, Livasy CA, Calvo B, Caskey L, Moore DT, Yang XH, and Cance WG: Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: Immunohistochemistry and real-time PCR analyses. Clinical Cancer Research 9: 215-222, 2003.
16. Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, Larocque N, Fisher SJ, Schiaepfer DD, and Llic D: Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Molecular Cell 29: 9-22, 2008.
17. Lo SH: Tensin. Int J Biochem Cell Biol 36: 31-34, 2004.
18. Lo SH and Bin Lo T: Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer. Cancer Research 62: 4217-4221, 2002.
19. McCarty KS, Miller LS, Cox EB and Konrath J: Estrogen-receptor analyses - correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Archives of Pathology & Laboratory Medicine 109: 716-721, 1985.
20. McKean DM, Sisbarro L, Ilic D, Kaplan-Alburquerque N, Nemenoff R, Weiser-Evans M, Kern MJ and Jones PL: FAK induces expression of Prx1 to promote tenascin-C-dependent fibroblast migration. Journal of Cell Biology 161: 393-402, 2003.
21. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5: 505-515, 2005.
22. Owens LV, Xu LH, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET and Cance WG: Overexpression of the focal adhesion kinase (p125(fak)) in invasive human tumors. Cancer Research 55: 2752-2755, 1995.
23. Schaller MD: Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochimica Et Biophysica Acta-Molecular Cell Research 1540: 1-21, 2001.
24. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB and Parsons JT: PP125FAK, a structurally distinctive proteintyrosine kinase associated with focal adhesions. Proceedings of the National Academy of Sciences of the United States of America 89: 5192-5196, 1992.
25. Schlaepfer DD, Hauck CR and Sieg DJ: Signaling through focal adhesion kinase. Progress in Biophysics & Molecular Biology 71: 435-478, 1999.
26. Theocharis SE, Kouraklis GP, Kakisis JD, Kanelli HG, Apostolakou FE, Karatzas GM and Koutselinis AS: Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 29: 571-574, 2003.
27. Tilghman RW, Slack-Davis JK, Sergina N, Martin KH, Iwanicki M, Hershey ED, Beggs HE, Relchardt LF and Parsons JT: Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells. Journal of Cell Science 118: 2613-2623, 2005.
28. Ullenhag GJ, Mukheriee A, Watson NFS, Ai-Attar AH, Scholefield JH and Durrant LG: Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients. Clinical Cancer Research 13: 5070-5075, 2007.
29. Xu L, Ownes LV, Sturge GC, Yang X, Liu ET, Craven RJ and Cance WG: Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Proceedings of the American Association for Cancer Research Annual Meeting 37: 19, 1996.
30. Xu LH, Yang XH, Craven RJ and Cance WG: The COOHterminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth & Differentiation 9: 999-1005, 1998.
31. Yu HG, Tong SL, Ding YM, Ding J, Fang XM, Zhang XF, Liu ZJ, Zhou YH, Liu QS, Luo HS and Yu JP: Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase. International journal of cancer Journal international du cancer 119: 2724-2732, 2006.
32. YuYing Chen KC, Feng Pan, Li Yang, JianJun Li, LiuXin Xiang, JianMing He, HouJie Liang Expressions of FAK, FAK pY397, Akt and NF-κB in colorectal carcinomas and study on their correlation. Chinese Clinical Oncology 14: 199-202 2009.
33. Zhao JH, Reiske H and Guan JL: Regulation of the cell cycle by focal adhesion kinase. Journal of Cell Biology 143: 1997-2008, 1998.